FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Urologische Klinik
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Overview
Publications
(495)
Research Grants
(3)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
RNA sequencing of collecting duct renal cell carcinoma suggests an interaction between miRNA and target genes and a predominance of deregulated solute carrier genes (2020)
Wach S, Taubert H, Weigelt K, Hase N, Köhn M, Misiak D, Hüttelmaier S, et al.
Journal article
The 27th annual meeting of the working group kidney transplantation of the German Society for Urology November 21-24, 2019 in Halle (Saale) (2019)
Weigand K, Friedersdorff F, Apel H, Stoeckle M, Putz J, Dreikorn K, Giessing M, Fornara P
Journal article, Editorial
Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer (2019)
Krumbholz M, Agaimy A, Stöhr R, Burger M, Wach S, Taubert H, Wullich B, et al.
Journal article
Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients (2019)
Abdulrahman A, Eckstein M, Jung R, Guzman J, Weigelt K, Serrero G, Yue B, et al.
Journal article
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma (2019)
Weyerer V, Weisser R, Moskalev E, Haller F, Stöhr R, Eckstein M, Zinnall U, et al.
Journal article
Efficacy of anti-PD(L)1 treatment in patients with metastatic urothelial cancer based on mRNA- and protein- based PD-L1 determination: Results from the multicentric, retrospective FOsMIC trial (2019)
Jarczyk J, Wirtz R, Roghmann F, Juette H, Kriegmair MC, Worst TS, Sikic D, et al.
Conference contribution
Prognostic role of FGFR Mutations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second-line setting (2019)
Roghmann F, Wirtz R, Jarczyk J, Kriegmair MC, Worst TS, Sikic D, Wach S, et al.
Conference contribution
Advanced renal cell carcinoma: First results from the prospective research platform CARAT for patients with mRCC in Germany (2019)
Goebell P, Mueller L, Gruellich C, Reichert D, Boegemann M, Doerfel S, Von Der Heyde E, et al.
Conference contribution
Evaluation of different diagnostic methods for identification of FGFR alteration in advanced urothelial carcinomas: Proficiency results based on multiple RNA extraction kits and mutation detection methods (2019)
Weyerer V, Stöhr R, Juette H, Wirtz R, Eckstein M, Roghmann F, Breyer J, et al.
Conference contribution
ZERO-BIOPSY AND KIDNEY TRANSPLANT FUNCTION OF DONOR KIDNEYS FROM ACCELERATED ORGAN ALLOCATION PROCEDURE (AOAP): REAL, RESCUE, CENTER OFFER COMPARED TO STANDARD EUROTRANSPLANT KIDNEY ALLOCATION SYSTEM (ETKAS) - SINGLE CENTER ANALYSIS 12/2013-12/2017 (2019)
Heller KM, Hendrik A, Wach S
Conference contribution
‹
1
...
21
22
23
24
25
...
49
›